Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Description 

This 4-part virtual learning collaborative will explore the use of injectable extended-release forms of Buprenorphine for the treatment OUD, with an emphasis on Sublocade due to it being on the market longer. This practical series will explore the nuts and bolts of getting people started on extended-release injectable buprenorphine, clinical considerations around using it for maintenance treatment, and using it in unique clinical situations such as pain, pregnancy, and adolescents. By the end of the course, our goal is that you will develop a level of expertise to confidently offer these medications as another treatment option for your patients with OUD.

Modules must be completed prior to attending the Live Session on September 20, 2024 from 2:00 - 3:00 PM EST. 

Learners must attend the Live Session on September 20, 2024 to claim credit for the live component of this course.

Modules and Content:

Module 1: What is injectable Buprenorphine and does it work?
Module 2: How do I start injectable buprenorphine?
Module 3: How Do I Use Injectable Buprenorphine for Maintenance Treatment?
Module 4: Using Injectable Buprenorphine in Special Populations

Pricing  

FREE - $0 

Learning Objectives  

Review and compare the two forms of injectable long-acting buprenorphine.
Describe the evidence base for their effectiveness in treating OUD.
Build confidence for knowing when and how to use injectable buprenorphine across the spectrum of OUD patients.

Target Audience  

Psychiatrists

Estimated Time to Complete 

Estimated Duration: 5.0 hours  

Program Begin Date: August 26, 2024

Program End Date: September 20, 2024  

Credit Claim End Date: November 19, 2024 

How to Earn Credit

Participants who wish to earn AMA PRA Category 1 Credit™ may do so after completing all sections of the course including the evaluation. After evaluating the program, course participants will be provided with an opportunity to claim hours of participation and print an official CME certificate (physicians) or certificate of participation (non-physicians) showing the completion date and hours earned.

Continuing Education Credit

In support of improving patient care, this activity has been planned and implemented by American Psychiatric Association (APA) and ORN. APA is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. The APA designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians

The APA designates this enduring activity for a maximum of 5.0 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty and Planner Disclosures 

The American Psychiatric Association adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Medical Education. Any individuals in a position to control the content of a CME activity — including faculty, planners, reviewers or others — are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.  

Instructor:  

• Mark Duncan, MD, University of Washington.

Planners: 

• Mark Duncan, MD, University of Washington.

Accessibility for Participants with Disabilities 

The American Psychiatric Association is committed to ensuring accessibility of its website to people with disabilities. If you have trouble accessing any of APA’s online resources, please contact us at 202-559-3900 for assistance.